KEY POINTS
- A2 Milk has declared a NZ$300 million special dividend (about A$245 million), worth 41.36 New Zealand cents per share, to be paid on 24 July 2026.
- In Australian dollar terms that is roughly 34 cents per share, a one-off yield of about 4.8% at the current price of A$7.10. The payment is fully franked, which adds extra value for Australian investors.
- The trigger was China’s approval to move two infant formula registrations onto the a2 brand, the final step in its Pokeno factory deal.
- Our view: a welcome cash return and a vote of confidence, but the long-term China birth rate challenge has not gone away.
A2 Milk (ASX:A2M) shares have traded sharply higher this week, settling around A$7.10 after the company formalised a rare treat for shareholders on Thursday: the official declaration of a large one-off cash payout. The board’s move follows an initial market jump on Monday, when the company first confirmed it had cleared its final regulatory hurdle in China. After a tough year for the stock, the question is whether this marks a turning point or just a one-off bright spot.
How big is the dividend, and what is the yield?
The special dividend is 41.36 New Zealand cents per share, adding up to about NZ$300 million in total, or roughly A$245 million. For investors on the ASX, who are paid in Australian dollars, the exact amount depends on the exchange rate A2 Milk uses on the conversion date. Based on current rates, that works out to around 34 cents per share. At the current price of A$7.10, that is a one-off yield of about 4.8%.
There is a bonus for Australian shareholders. The dividend is fully franked, which means it comes with tax credits that can make it worth more than the cash figure alone. The money is due to be paid on 24 July 2026. Just remember this is a special, one-time payment, not a regular dividend you can count on every year.
Why is A2 Milk paying it now?
The trigger was a green light from China’s market regulator, SAMR. It approved A2 Milk’s plan to move two China-label infant formula registrations onto its core a2 brand. These registrations came with the company’s Pokeno factory in New Zealand, and the approval was the last box to tick on that deal.
Why does that matter? It means A2 Milk now fully owns and controls high-margin manufacturing capacity for its most important market. New products using these registrations are expected to launch later in 2026. In short, the approval turns a long-held plan into real earning power, and the company felt confident enough to return cash to shareholders at the same time.
So, is A2 Milk a buy?
This is clearly good news, and the market agreed. But a little caution helps here. A2 Milk shares have already jumped more than 30% since early June, so a lot of the good news may already be in the price. Over the past year, the stock is still down about 17%.
The bigger issue is the long-term backdrop. A2 Milk depends heavily on selling infant formula in China, where birth rates have been falling for years. That makes it harder to grow, even with a strong brand. The special dividend is a nice reward and a sign of confidence, but it does not fix that challenge.
The bottom line: for current holders, this is a solid cash return and a positive signal. For new buyers, the sharp run-up means it may pay to wait for a calmer entry point rather than chasing the stock after the jump.
